According to the latest report by IMARC Group, titled “Human Microbiome Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, the global human microbiome market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 18% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/human-microbiome-market/requestsample
The human microbiome represents the genes present within the microorganisms found in the genetic portrait or metagenome of humans. It comprises numerous microorganisms, such as bacteria, protozoa, fungi, non-living viruses, single-celled organisms, etc., which impact human physiology and promote the enhancement or impairment of immune and metabolic functions. They are found in human tissues and are studied for various medical advancements and analytical techniques. Microbiomes are utilized in prebiotics, probiotics, pharmaceutical drugs, diagnostic and therapeutic systems, etc., for different ailments, including diabetes, obesity, cancer, etc., and disorders such as metabolic, neurological, gastrointestinal, central nervous system, autoimmune, etc.
The growing incidences of infections and chronic lifestyle diseases across the globe owing to microbial dysbiosis are among the key factors driving the human microbiome market. Moreover, the expanding geriatric population, who are more susceptible to such ailments, is further propelling the product demand. In addition to this, the elevating focus on developing human microbiome therapeutics with enhanced efficacy is acting as another growth-inducing factor. Furthermore, the sudden onset of the COVID-19 pandemic is also bolstering the market growth since researchers are extensively studying the lung microbiomes to determine the severity of the infections and to produce appropriate therapeutics and vaccines. Besides this, various advancements in target-specific microbiome-based therapies are anticipated to fuel the human microbiome market over the forecasted period.
Human Microbiome Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global human microbiome market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- 4D pharma plc
- Atlas Biomed Group Limited
- DayTwo Inc.
- Ferring B.V.
- Finch Therapeutics
- Second Genome Inc.
- SynBioBeta LLC
- Synthetic Biologics Inc.
- Vedanta Biosciences Inc.
- Viome Inc.
Key Market Segmentation:
The report has segmented the global human microbiome market on the basis of product, application, disease type and region.
Breakup by Product:
- Diagnostic Tests
- Medical Food
Breakup by Application:
Breakup by Disease Type:
- Autoimmune Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/human-microbiome-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800